State Street Corp decreased its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) by 5.1% during the third quarter, Holdings Channel.com reports. The firm owned 604,796 shares of the company’s stock after selling 32,378 shares during the period. State Street Corp’s holdings in Viemed Healthcare were worth $4,433,000 at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of the business. Oppenheimer Asset Management Inc. boosted its holdings in shares of Viemed Healthcare by 5.6% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 30,222 shares of the company’s stock worth $222,000 after purchasing an additional 1,601 shares during the period. The Manufacturers Life Insurance Company boosted its stake in Viemed Healthcare by 14.7% during the second quarter. The Manufacturers Life Insurance Company now owns 14,918 shares of the company’s stock worth $98,000 after buying an additional 1,912 shares during the period. Victory Capital Management Inc. raised its stake in shares of Viemed Healthcare by 21.1% in the second quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock valued at $84,000 after acquiring an additional 2,226 shares during the period. Panagora Asset Management Inc. lifted its holdings in shares of Viemed Healthcare by 1.1% in the 2nd quarter. Panagora Asset Management Inc. now owns 272,383 shares of the company’s stock worth $1,784,000 after acquiring an additional 2,904 shares during the last quarter. Finally, Rhumbline Advisers boosted its stake in shares of Viemed Healthcare by 9.4% during the 2nd quarter. Rhumbline Advisers now owns 42,011 shares of the company’s stock worth $275,000 after purchasing an additional 3,613 shares during the period. Institutional investors own 74.24% of the company’s stock.
Viemed Healthcare Stock Performance
Viemed Healthcare stock opened at $8.16 on Monday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The firm has a market capitalization of $317.73 million, a P/E ratio of 30.22 and a beta of 1.46. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $10.44. The company’s 50-day moving average is $8.72 and its 200 day moving average is $7.79.
Insider Transactions at Viemed Healthcare
In other news, Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the transaction, the director now owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. This represents a 25.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Nitin Kaushal sold 5,995 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $8.58, for a total value of $51,437.10. Following the transaction, the director now owns 126,843 shares in the company, valued at approximately $1,088,312.94. This represents a 4.51 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 72,256 shares of company stock worth $674,739. 20.00% of the stock is currently owned by insiders.
Viemed Healthcare Profile
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Articles
- Five stocks we like better than Viemed Healthcare
- How Investors Can Find the Best Cheap Dividend Stocks
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- What is the Nasdaq? Complete Overview with History
- These 3 Quirky ETFs May Be Strong Plays in 2025
- The Basics of Support and Resistance
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report).
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.